Perhaps glucocorticoids modulate the expression pattern of angiotensin II receptors in the heart, which produces an intracellular environment conducive for cardioprotective factors such as PKCε and COX-2 to predominate, resulting in increased protection of the heart against ischemia and reperfusion injury. The gene discussed is PTGS2; the disease is ischemia.